Differentiation of primary gliomas from metastases using a novel advanced diffusion sequence in MRI

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200064963

Enrollment

Unknown

Registered

2022-10-24

Start date

2022-10-31

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glioma, Brain metastasis

Interventions

Group 1:

Group 2:

Eligibility

Sex/Gender

All

Age

1 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. The patient has a mass in the brain found by head CT or MR examination; 2. No treatment for brain lesions before receiving MRI examination; 3. Surgical or pathological biopsy confirmed that the lesion was primary brain glioma or brain metastases, and the IDH gene phenotype of the glioma was clarified.

Exclusion criteria

Exclusion criteria: 1. Patients with MRI scanning contraindications such as claustrophobia or cardiac pacemaker implantation; 2. The patient's cooperation is not good, and there are obvious artifacts in the scanned MRI images.

Design outcomes

Primary

Measure	Time frame
cell diameter;intracellular volume fraction;intracellular diffusion coefficient;extracellular diffusion coefficient;	—

Countries

China

Contacts

Public ContactJiaji Mao

Sun Yat-sen Memorial Hospital, Sun Yat-sen University

maojj6@mail.sysu.edu.cn+86 13570978338

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026